Rock Springs Capital Management LP Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$3.9B
Holdings
127
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (127 positions)
| Stock | Value |
|---|---|
HUMHUMANA INC | $206.9M |
AGLAGILON HEALTH INC | $181.4M |
IMCRIMMUNOCORE HLDGS PLC | $164.0M |
UNHUNITEDHEALTH GROUP INC | $136.1M |
ARGXARGENX SE | $123.6M |
NBIXNEUROCRINE BIOSCIENCES INC | $119.2M |
PODDINSULET CORP | $118.9M |
EVHEVOLENT HEALTH INC | $117.2M |
2L9BLUEPRINT MEDICINES CORP | $101.4M |
KRTXKARUNA THERAPEUTICS INC | $93.1M |
PENPENUMBRA INC | $90.3M |
AGIOAGIOS PHARMACEUTICALS INC | $86.5M |
IDXXIDEXX LABS INC | $73.1M |
AFWALIGN TECHNOLOGY INC | $71.2M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $70.6M |
ALNYALNYLAM PHARMACEUTICALS INC | $66.6M |
ACHCACADIA HEALTHCARE COMPANY IN | $66.1M |
ACRSACLARIS THERAPEUTICS INC | $62.4M |
MRTXEURMIRATI THERAPEUTICS INC | $60.5M |
ISRGINTUITIVE SURGICAL INC | $56.0M |
PCRXPACIRA BIOSCIENCES INC | $54.1M |
EWEDWARDS LIFESCIENCES CORP | $52.1M |
SWAVUSDSHOCKWAVE MED INC | $50.1M |
RAREULTRAGENYX PHARMACEUTICAL IN | $49.2M |
SRPTSAREPTA THERAPEUTICS INC | $47.5M |
AKROAKERO THERAPEUTICS INC | $46.6M |
HZNPHORIZON THERAPEUTICS PUB L | $45.0M |
WSTWEST PHARMACEUTICAL SVSC INC | $44.4M |
ASNDASCENDIS PHARMA A/S | $43.9M |
RYTMRHYTHM PHARMACEUTICALS INC | $43.1M |
XENEXENON PHARMACEUTICALS INC | $41.7M |
PRTAPROTHENA CORP PLC | $41.1M |
ZLABZAI LAB LTD | $40.8M |
BAXBAXTER INTL INC | $40.7M |
—CINCOR PHARMA INC | $39.6M |
DC4DEXCOM INC | $39.5M |
—PROMETHEUS BIOSCIENCES INC | $38.1M |
MIRMMIRUM PHARMACEUTICALS INC | $37.7M |
SGENUSDSEAGEN INC | $37.2M |
IRTCIRHYTHM TECHNOLOGIES INC | $36.7M |
NVROEURNEVRO CORP | $36.7M |
FRPTFRESHPET INC | $35.1M |
CVETUSDCOVETRUS INC | $35.1M |
PHRPHREESIA INC | $33.2M |
—ABCAM PLC | $30.5M |
—MERSANA THERAPEUTICS INC | $27.6M |
ACCDEURACCOLADE INC | $26.0M |
XLVSELECT SECTOR SPDR TR | $24.2M |
TVTXTRAVERE THERAPEUTICS INC | $23.4M |
KYMRKYMERA THERAPEUTICS INC | $22.8M |
BMRNBIOMARIN PHARMACEUTICAL INC | $22.4M |
BCRXBIOCRYST PHARMACEUTICALS INC | $21.6M |
CYTKCYTOKINETICS INC | $21.5M |
MDGLMADRIGAL PHARMACEUTICALS INC | $20.6M |
VERVVERVE THERAPEUTICS INC | $19.2M |
GOSSGOSSAMER BIO INC | $19.0M |
EXASEXACT SCIENCES CORP | $18.8M |
CNMDCONMED CORP | $18.7M |
AURAAURA BIOSCIENCES INC | $18.4M |
LEGNLEGEND BIOTECH CORP | $18.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $17.6M |
—OLINK HLDG AB | $17.5M |
WRBYWARBY PARKER INC | $17.5M |
IMTXIMMATICS N.V | $16.8M |
ANABANAPTYSBIO INC | $14.7M |
AZTAAZENTA INC | $14.2M |
RLAYRELAY THERAPEUTICS INC | $13.8M |
NVCRNOVOCURE LTD | $13.3M |
LFSTLIFESTANCE HEALTH GROUP INC | $13.2M |
ARVNARVINAS INC | $12.5M |
CMPXCOMPASS THERAPEUTICS INC | $12.2M |
TCE2CELLDEX THERAPEUTICS INC NEW | $11.9M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $11.6M |
AMLXAMYLYX PHARMACEUTICALS INC | $11.4M |
NVV1NOVAVAX INC | $10.9M |
GHGUARDANT HEALTH INC | $10.8M |
AM6AMICUS THERAPEUTICS INC | $10.6M |
290ACHINOOK THERAPEUTICS INC | $10.0M |
LUNGPULMONX CORP | $10.0M |
GOSS 5 06/01/27GOSSAMER BIO INC | $9.9M |
—ORION ACQUISITION CORP | $9.9M |
—AMRYT PHARMA PLC | $9.2M |
—KINNATE BIOPHARMA INC | $8.9M |
HCATHEALTH CATALYST INC | $8.5M |
NVTA1EURINVITAE CORP | $8.3M |
NKTXNKARTA INC | $8.1M |
AUPHAURINIA PHARMACEUTICALS INC | $8.0M |
DSGNDESIGN THERAPEUTICS INC | $7.7M |
INZYINOZYME PHARMA INC | $7.5M |
EDAEDAP TMS S A | $7.5M |
BMEABIOMEA FUSION INC | $7.1M |
—GAMIDA CELL LTD | $6.6M |
MREOMEREO BIOPHARMA GROUP PLC | $5.4M |
BEAMBEAM THERAPEUTICS INC | $5.3M |
—EQRX INC | $5.0M |
—PARATEK PHARMACEUTICALS INC | $4.5M |
VIGLVIGIL NEUROSCIENCE INC | $4.3M |
MGNXMACROGENICS INC | $4.2M |
XLOXILIO THERAPEUTICS INC | $4.0M |
—F-STAR THERAPEUTICS INC | $3.9M |
Page 1 of 2Next